Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 3 results for author "Pankit J Vachhani".

Back to authors

Thumbnail for Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

MPN - 1268

Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for Characterization of Symptoms After Immediate Transition From Ruxolitinib to Momelotinib in Patients With Myelofibrosis: Post-Hoc Analyses of the Phase 3 SIMPLIFY-1 and SIMPLIFY-2 Trials

MPN - 318

Characterization of Symptoms After Immediate Transition From Ruxolitinib to Momelotinib in Patients With Myelofibrosis: Post-Hoc Analyses of the Phase 3 SIMPLIFY-1 and SIMPLIFY-2 Trials

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

MPN - 973

A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors